UC HEALTH LINE: First Comprehensive Pain Center Opening in the Tristate
Its one that can be difficult to treat because its subjective, and treatments that work for one person may not work for another.
The condition, chronic pain, affects more Americans than heart disease, diabetes and cancer combined.
Severe chronic pain affects every aspect of a persons life, says the Harvard-trained Hamman Akbik, MD, assistant professor and director of pain management services at the
There are various treatments for painfrom medical management and physical therapy to injection and even psychological therapy. Because of the multidisciplinary nature of treating chronic pain, the
The pain center, currently located in the main medical office building at University Pointe in West Chester, is moving into its own office on the University Pointe campus, where Akbik and his colleague Muhammad Munir, MD, will begin seeing patients at its new location (
This larger space allows us to practice multidisciplinary pain management in state-of-the-art suites, says Akbik. Some patients may even be evaluated and receive a procedure the same day, resulting in less time off work.
In addition, patients who require physical therapy and counseling as part of their pain management treatment plan no longer have to visit specialists at another locationits all available at the comprehensive pain center.
Our goal is to reduce our patients pain, improve the quality of their life and increase their activity level.
Treatments are tailored to the individual, because an approach that works for one patient may not work for another, and we can now offer these services to our patients in one location, Akbik says.
For more information or to schedule an appointment at
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.